Home › Stocks › NRIX › All Fund Holders
NRIX — NURIX THERAPEUTICS INC · All Fund Holders
Funds holding (latest): 44 · Reported value held: $910.30M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 8.77M | $212.77M | 0.00% | Reduce |
| Fidelity Management & Research (FMR) history | Q2 2026 | 5.49M | $133.07M | 0.01% | Reduce |
| Morgan Stanley history | Q2 2026 | 4.76M | $115.54M | 0.01% | Reduce |
| Vanguard Group history | Q4 2025 | 5.95M | $112.86M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 2.54M | $61.57M | 0.00% | Add |
| ARK Invest history | Q2 2026 | 1.79M | $43.50M | 0.28% | Add |
| Capital World Investors history | Q2 2026 | 1.79M | $43.37M | 0.01% | Add |
| UBS Group AG history | Q2 2026 | 917.12K | $22.25M | 0.01% | Reduce |
| Northern Trust Corp history | Q2 2026 | 876.07K | $21.25M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 842.09K | $20.43M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 833.30K | $20.22M | 0.00% | Reduce |
| Goldman Sachs Group history | Q2 2026 | 813.59K | $19.74M | 0.01% | Reduce |
| Arrowstreet Capital history | Q2 2026 | 477.14K | $11.58M | 0.01% | New |
| Citigroup Inc history | Q2 2026 | 389.38K | $9.45M | 0.00% | Reduce |
| Wellington Management Group history | Q2 2026 | 334.14K | $8.11M | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 272.64K | $6.61M | 0.00% | Reduce |
| Norges Bank Investment Management history | Q4 2024 | 318.80K | $6.01M | 0.00% | Reduce |
| D. E. Shaw & Co history | Q2 2026 | 184.55K | $4.48M | 0.00% | Reduce |
| AQR Capital Management history | Q2 2026 | 179.46K | $4.35M | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 178.05K | $4.32M | 0.00% | Reduce |
| Manulife Financial history | Q2 2026 | 168.86K | $4.10M | 0.00% | Reduce |
| Deutsche Bank AG history | Q2 2026 | 151.45K | $3.67M | 0.00% | Reduce |
| Prudential Financial history | Q2 2026 | 145.17K | $3.52M | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 103.57K | $2.51M | 0.00% | Add |
| Marshall Wace history | Q3 2025 | 246.79K | $2.28M | 0.00% | New |
| Farallon Capital Management history | Q2 2024 | 108.80K | $2.27M | 0.01% | New |
| Renaissance Technologies history | Q1 2026 | 118.00K | $1.83M | 0.00% | New |
| Point72 Asset Management history | Q2 2026 | 73.07K | $1.77M | 0.01% | Reduce |
| Legal & General Investment Management America history | Q2 2026 | 72.03K | $1.75M | 0.00% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 48.69K | $1.16M | 0.00% | New |
| MFS Investment Management history | Q1 2026 | 42.60K | $660.35K | 0.00% | Reduce |
| Balyasny Asset Management history | Q2 2026 | 27.07K | $656.62K | 0.00% | New |
| Janus Henderson Group history | Q1 2026 | 39.40K | $610.11K | 0.00% | Hold |
| Two Sigma Investments history | Q3 2025 | 62.88K | $580.97K | 0.00% | Reduce |
| Millennium Management history | Q2 2026 | 20.91K | $507.28K | 0.00% | Reduce |
| Citadel Advisors history | Q2 2026 | 11.40K | $276.56K | 0.00% | Reduce |
| Franklin Resources history | Q3 2025 | 29.08K | $268.67K | 0.00% | Reduce |
| Principal Global Investors history | Q1 2024 | 12.95K | $190.41K | 0.00% | Reduce |
| T. Rowe Price Associates history | Q2 2026 | 5.44M | $131.89K | 0.01% | Add |
| CPP Investments history | Q4 2025 | 3.30K | $62.60K | 0.00% | New |
| PNC Financial Services history | Q2 2026 | 600 | $14.56K | 0.00% | Add |
| Harvard Management Company history | Q2 2023 | 314.76K | $3.14K | 0.31% | Hold |
| Amundi US history | Q1 2025 | 17 | $179 | 0.00% | Hold |
| Lazard Asset Management history | Q4 2024 | 2.15K | $40 | 0.00% | Hold |